Novistra Capital
transaction-bg-2560x945

August 2018

United States & India

Novistra Capital advised Pacific BPO on its sale to Access Healthcare

Client

Pacific BPO

Deal Type

Sell-Side M&A

Deal Team

Ripun-1-120x120

Ripun Jai Mehta

Managing Partner

Pankaj-1-120x120

Pankaj Arora

Managing Director

Anuj-2-1-120x120

Anuj Jaisinghani

Associate Director

Client Description

Pacific BPO, founded in 2010 and headquartered in Noida, India, is a leading Revenue Cycle Management (RCM) company providing medical billing, coding, and accounts receivable services to U.S. healthcare providers. With over 2,100 employees across five offices in the U.S. and India, Pacific serves a diversified client base spanning hospitals, physician groups, and third-party billing companies.

Access Healthcare, based in Dallas, TX, is one of the fastest-growing RCM companies in the U.S., serving over 250,000 physicians, 80+ medical specialties, and processing $50 billion+ in accounts receivables annually. With a strong global presence and technology-led service delivery, Access operates 19 global delivery centers across three countries.

Approach

Pacific BPO appointed Novistra Capital as its exclusive M&A advisor to explore strategic exit opportunities with the right long-term partner. The goal was to unlock growth synergies, expand global scale, and create value for both shareholders and clients.

With deep experience in healthcare outsourcing and cross-border transactions, Novistra led the transaction from initial positioning and buyer engagement through to final execution—managing all commercial and strategic workstreams.

Outcome

Access Healthcare acquired Pacific BPO, adding delivery scale, service depth, and operational flexibility to its global platform. The transaction expanded Access Healthcare’s headcount to over 11,000 employees, solidifying its position as a category leader in global RCM solutions.

This deal highlights Novistra’s strength in the RCM and healthcare BPO sector, particularly in the U.S.–India corridor, and reinforces its ability to deliver strategic outcomes for founder-led platforms.

Press Releases

healthcare-2560x390

September, 2018

Novistra Capital advises Pacific BPO on its sale to Access Healthcare

Read more
Access-Healthcare-Logo-3-2560x267

August, 2018

Access Healthcare acquires revenue cycle services provider Pacific BPO

Read more

Related Transactions

Acquired

Buy-side advisor to CX1 Capital

Novistra Capital advises CX1 Capital on its acquisition of SatCom Marketing

Novistra Capital advises CX1 Capital on its acquisition of SatCom Marketing

Outcome: Exclusive buy-side advisor to CX1 Capital, a tech-driven investment firm that focuses on lower middle market buy & build strategies using AI.

Acquired by

A portfolio company of

Sell-side advisor to CTI Data

Novistra Capital advises CTI Data on its sale to OneSix

Exclusive sell-side advisor to CTI Data, a leading data consultancy, on its sale to OneSix,...

Outcome: Acquisition creates a differentiated Snowflake data and scaled AI platform.

Acquired by

A portfolio company of

Sell-side advisor to Yexle

Novistra Capital advises Yexle on its sale to IGT Solutions, an EQT portfolio company

Exclusive sell-side advisor to Yexle, a leading Appian solutions and services partner.

Outcome: Added cutting-edge Appian delivery capabilities to IGT’s digital transformation practice.

Acquired by

A portfolio company of

Sell-side advisor to NetServ

Novistra Capital advised NetServ on its acquisition by Accion Labs, a portfolio company of TA Associates

Served as exclusive sell-side advisor to NetServ on its acquisition by Accion Labs, a global...

Outcome: Strengthened engineering capabilities and delivery presence across key markets

Acquired by

A portfolio company of

Sell-side advisor to SG Analytics

Novistra Capital advised SG Analytics on its acquisition by Straive, a portfolio company of EQT

SG Analytics engaged Novistra Capital as its exclusive sell-side advisor on its acquisition by Straive,...

Outcome: Created one of the leading integrated data and analytics platforms

Acquired by

A portfolio company of

Sell-side advisor to Cloud Development Resources

Novistra Capital advised Cloud Development Resources on its majority sale to emids

CDR engaged Novistra Capital to lead a targeted process culminating in its sale to emids,...

Outcome: Established the healthcare industry’s first dedicated low-code practice

Majority investment in

Buy-side advisor to Excelra

Novistra Capital advised Excelra on its majority investment in Anilitiks

Served as exclusive buy-side advisor to Excelra on its acquisition of Anilitiks, strengthening Excelra’s HEOR...

Outcome: Expanded Excelra’s data-driven Life Sciences solutions portfolio

Merged with

Buy-side advisor to ACN Healthcare

Novistra Capital advised ACN Healthcare on its merger with Rapid Care’s RCM business

Advised ACN Healthcare on its merger with the RCM business of Rapid Care Group, creating...

Outcome: Merger created a scaled, integrated healthcare RCM platform

License agreement with

Financial advisor to IDD Bio Tech

Novistra Capital advised IDD Biotech on its license agreement with Enzene Biosciences, a subsidiary of Alkem Labs

IDD Biotech appointed Novistra Capital to structure and negotiate a licensing deal for its CD19...

Outcome: Exclusive licensing agreement with Enzene Biosciences completed

Acquired by

Sell-side advisor to Global Revenue Cycle Partners

Novistra Capital advises Global Revenue Cycle Partners on its majority exit to ACN Technologies

Advised Global Revenue Cycle Partners on its majority sale to ACN Technologies, creating an integrated...

Outcome: Leveraged ACN’s US and European presence to expand offerings

Rectangle-426-1-scaled-2560x718

Clarity starts with
a conversation